▲ Signing ceremony photo

 ▲ Signing ceremony photo 2

PCMO (Director: Cho Min, hereinafter referred to as "the Center") announced on the 11th that it has signed a Memorandum of Understanding (MOU) with the Bio Campus of Korea Polytechnics to foster professional talent in the bio sector.

This agreement aims to establish a collaborative framework for cultivating skilled professionals in the bio industry by sharing the latest trends in education and career exploration. The Center and the Bio Campus plan to expand hands-on education and field training opportunities by leveraging each institution's expertise and infrastructure.

Key areas of cooperation include:

▲ Joint use of facilities and equipment

▲ Sharing admissions and career-related information

▲ Exchanging know-how in professional workforce development

▲ Collaborating on curriculum design and implementation

▲ Logos of Korea Polytechnics Bio Campus and PCMO

Korea Polytechnics Bio Campus is the only bio-specialized campus in the nation. It offers five specialized departments: Bioprocess Engineering, Biopharmaceutical Analysis, Bioquality Control, Bionanomaterials, and Bioinformatics. Over the past three years, it has achieved an average employment rate of 88.6%, with 87.1% employed by large and mid-sized companies, and a 93.6% full-time employment rate. Notably, 46 graduates have joined Samsung Biologics, among other leading companies in Korea’s bio industry.

Meanwhile, the Center is set to launch a full-scale training program in June 2025 through its new Training center, part of the Vaccine Industry Talent Development Project supported by the Ministry of Trade, Industry and Energy and Hwasun County. The Center aims to train over 900 individuals by 2026 and is also contributing to the World Health Organization (WHO)’s Global Bio Campus initiative, supporting global vaccine capacity building as well as regional development.

The training center, scheduled for completion in June 2025, will serve as the largest GMP hands-on training facility in the Gwangju-Jeonnam region. It is expected to generate strong synergy in future academia-industry cooperation. The facility will offer practical training in pharmaceutical manufacturing and quality control using state-of-the-art equipment including 50L bioreactors, autoclaves, continuous centrifuges, HPLC, and LC-MS systems.

A representative from the Center stated, “This agreement will provide students with close exposure to real-world bio manufacturing sites and serve as a stepping stone to becoming key leaders in the industry,” adding, “We will continue to strengthen educational partnerships to nurture the future of the bio field.”